UPPSALA, Sweden — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations. He will report to Carl Raimond, President of Olink. […]
Services support peptide purification, custom synthesis of PEC-grade peptides, and development and production of peptide drugs and drug candidates PurePep® EasyClean (PEC) orthogonal purification technology for peptide purification now fully integrated into Company’s kits and services offerings Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale […]
The addition of the LSA increases Icosagen’s end-to-end service capabilities for drug companies developing therapeutics worldwide Tartu, Estonia and Salt Lake City, Utah, USA — Icosagen Group, an established research-driven organization providing services for the discovery and production of mammalian cell-derived biopharmaceuticals, today announced that it has acquired the LSA® platform from Carterra®, a leading provider of […]
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY — Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has entered into an agreement for Labcorp (NYSE: LH) to acquire the assets of Enzo’s Clinical Laboratory division (Enzo Clinical Labs). The transaction between two leading global life sciences companies follows several […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its participation in the Cell and Gene Therapy Catapult Process Analytical Technology (Catapult PAT) consortium, a multi-year collaboration involving 24 partner companies, technology providers, therapy developers, and charities. The Catapult PAT consortium is the first initiative of this scale and functional expertise with member companies […]
BOULDER, Colo. — SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the China Kadoorie Biobank (CKB), one of the world’s largest prospective studies. The SomaLogic team provided more than 28 million data points from the assay which will be combined with other […]
— Integrated offering to be highlighted at Festival of Biologics — — Tracey Mullen, MBA, to lead Twist Biopharma Solutions — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an integrated offering of antibody discovery services available to […]
GAINESVILLE, Fla. — Evanoa Bioscience Inc., a cell line developer for biologics manufacturing, together with Aldevron®, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, today announced the signing of a licensing agreement for two E. coli strains to be used in plasmid production. Evanoa is using […]
Spectrum Solutions’ offerings enhanced by including CLIA/CAP laboratory testing, custom assay development, and manufacturing of industry-leading microarray chip technology. SALT LAKE CITY — Spectrum Solutions® today announced the acquisitions of Alimetrix, Inc., a CLIA and CAP accredited molecular diagnostic laboratory skilled at custom qualitative and quantitative assay development, and Microarrays, Inc., a leader in customer array-based […]
Researchers from Buck Institute for Research on Aging, Brigham Young University and University of Southern California awarded early access to Nautilus’ single-molecule protein analysis platform SEATTLE — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the selection of three research proposals submitted to […]
Pay Invoice
Latest Blogs
-
Dividends as an Indicator for Laboratory Tool Industry Companies in 2022
February 1, 2023 9:00 am
-
Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids
January 5, 2023 9:13 pm
-
Danaher Investor Day 2022 Showcases Big Announcements and Focuses on Cytiva
September 27, 2022 5:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.